Brian M. Slomovitz - Concepedia

Author

Brian M. Slomovitz

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Aurelien Marabelle, B M Slomovitz, B Slomovitz, B. M. Slomovitz, B. Slomovitz, B.M. SLOMOVITZ, B.M. Slomovitz, Brian M Slomovitz, Brian M. Slomovitz, Brian Slomovitz

425

Publications

11.3K

Citations

H-Index

110

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center University of Miami Mount Sinai Medical Center Sylvester Comprehensive Cancer Center Cornell University

About

Brian M. Slomovitz is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	55	3.9K
2	Public Health	9	9	443
3	Health Sciences	8	8	410
4	Cell Biology	4	4	97
5	Cellular Therapies	1	1	131

Brian M. Slomovitz

102

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Robert L. Coleman, Amit M. Oza, Domenica Lorusso, The Lancet Rucaparib Maintenance TreatmentMedicineRecurrent Ovarian CarcinomaGynecologyCancer Treatment	2017	1.7K
Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome Kathleen M. Schmeler, Henry T. Lynch, Lee-may Chen, New England Journal of Medicine	2006	783
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz, New England Journal of Medicine	2023	718
Risk Factors for Young Premenopausal Women With Endometrial Cancer Pamela T. Soliman, Jonathan C. Oh, Kathleen M. Schmeler, Obstetrics and Gynecology	2005	359
Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma Brian M. Slomovitz, Yunyun Jiang, Melinda S. Yates, Journal of Clinical Oncology	2015	312
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma Brian M. Slomovitz, Karen H. Lu, Taren Johnston, Cancer	2010	275
Comparison of Total Laparoscopic and Abdominal Radical Hysterectomy for Patients With Early-Stage Cervical Cancer Michael Frumovitz, Ricardo dos Reis, Charlotte C. Sun, Obstetrics and Gynecology	2007	253
Association between adiponectin, insulin resistance, and endometrial cancer Pamela T. Soliman, Diana Wu, Guillermo Tortolero‐Luna, Cancer	2006	230
Her-2/<i>neu</i> Overexpression and Amplification in Uterine Papillary Serous Carcinoma Brian M. Slomovitz, Russell R. Broaddus, Thomas W. Burke, Journal of Clinical Oncology	2004	223
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial Johann S. de Bono, Nicole Concin, David S. Hong, The Lancet Oncology Innovatv 201Tisotumab VedotinMedicineImmunologyClinical Trials	2019	217

Page 1